JPRN-UMIN000029816已完成未知
ovel treatment for refractory neuroblastoma by using poliovirus; phase I clinical trial - Novel treatment for refractory neuroblastoma by using poliovirus; phase I clinical trial
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 3
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18months-old 至 120months-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •patients who have paralysis
研究者
相似试验
招募中
不适用
Response-based treatment of high-risk neuroblastomaNeoplasmsKCT0002038Samsung Medical Center54
已完成
1 期
Safety Study of Nifurtimox for Relapsed or Refractory NeuroblastomaNeuroblastomaNCT00486564University of Vermont20
已完成
3 期
STOP NEUROMA Surgical Treatment Of symPtomatic NEUROMA: Open non-randomized clinical investigation to evaluate the safety and effectiveness of the nerve capping device to prevent neuroma formation after traumatic nerve sectionerve fantom painsymptomatic neuroma10034606NL-OMON43604Polyganics BV, Groningen20
进行中（未招募）
1 期
Study to evaluate the potentiation effect of radiotherapy by AGuIX nanoparticles for the treatment of persistent glioblastomaPersistent Glioblastoma Multiforme, grade IVMedDRA version: 20.0Level: PTClassification code 10018337Term: Glioblastoma multiformeSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2021-003774-32-ITDIPARTIMENTO BIOMEDICINA E PREVENZIONE UNIVERSITà DEGLI STUDI DI ROMA TOR VERGATA30
No Longer Available
不适用
Expanded Access Protocol Using 131I-MIBG Therapy +/- Vorinostat for Refractory Neuroblastoma, Pheochromocytoma, or ParagangliomaNeuroblastomaParagangliomaPheochromocytomaNCT01838187Children's Hospital Medical Center, Cincinnati